GPU Senior Editor Jarred Walton tested the EVGA GeForce RTX 3050 XC Black (using reference clocks) and the Zotac GeForce RTX ...

Oct. 26 (UPI) --Chip-maker Nvidia on Friday briefly became the world's most valuable company after surpassing Apple in total market value, but Apple regained its top position by the close of trading.

Oct 25 (Reuters) - Nvidia (NVDA.O), opens new tab dethroned Apple (AAPL.O), opens new tab as the world's most valuable company on Friday following a record-setting rally in the stock, powered by ...

Nvidia dethroned has Apple as the world's most valuable company, following a record-setting rally in the stock powered by an insatiable demand for its new super-computing AI chips. Nvidia's stock ...

Nvidia's market cap leapfrogs Apple, signaling a new titan in tech. AI supercomputing chips fuel Nvidia's stock surge, hinting at the future of tech dominance. What Happened: On Friday, Nvidia’s ...

Finley has led the tight ends since his hiring in January 2021 and was promoted to co-OC alongside Seth Littrell late last year. With Littrell’s midseason firing, Finley will serve as play ...

a launcher that includes the games Call of Duty: Modern Warfare III and Call of Duty: Warzone (available on Xbox and PC Game Pass). The new GeForce Now release list includes: ...

Then-assistant OC Sheriff George Jaramillo speaks to then-Sheriff Mike Carona (Jebb Harris, OC Register/SCNG) And who can forget former Sheriff Mike Carona and his right-hand man, George Jaramillo?

Nvidia's latest Game Ready GeForce driver (566.03) is out and should optimise your rig for some new and upcoming games and DLC, but Corsair iCUE or Bluestacks users might want to hold off on ...

28, 2024. Credit: ERIKA TAYLOR, Voice of OC Consider starting your weekend this Saturday by checking out books at the mobile library stop at MoonGoat Coffee, or by taking the kids on a family hike.

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.